Slalom and OpenAI outline a framework for operationalizing responsible AI across healthcare and life sciences, targeting governance, compliance, data privacy and clinical safety as core priorities. The guidance emphasizes scalable policies, risk management, model validation and pilot-to-production pathways that align with healthcare regulation. It advocates cross-functional governance, vendor risk assessments and technical controls to reduce patient safety and privacy risks while accelerating AI adoption.
The resource presents practical implementation steps—model fine-tuning on de-identified data, continuous monitoring and auditing, explainability measures and human-in-the-loop workflows—to maintain clinical oversight. It also recommends workforce training, change management and metrics for performance, safety and equity. The partnership frames responsible AI as a business enabler for decision support, operational efficiency and drug development, tempered by a cautious, compliance-first approach.
